Clinical Trial Update: Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing routes of administration of the personalized cancer vaccine Oncophage (HSPPC-96) in metastatic renal cell carcinoma; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Oncophage

Snippet

Sponsor: Agenus Inc. | Conditions: Renal Cell Carcinoma | Phase 2 | Status: TERMINATED